Mc Clarren Financial Advisors, Inc. Novartis Ag Transaction History
Mc Clarren Financial Advisors, Inc.
- $795 Million
- Q3 2024
A detailed history of Mc Clarren Financial Advisors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Mc Clarren Financial Advisors, Inc. holds 121 shares of NVS stock, worth $11,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
121
Previous 212
42.92%
Holding current value
$11,900
Previous $25,000
12.0%
% of portfolio
0.0%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding NVS
# of Institutions
1,437Shares Held
131MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.2 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.18 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$796 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$687 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$567 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $212B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...